Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization

Neovascularization (NV) of the cornea can disrupt visual function, causing ocular diseases, including blindness. Therefore, treatment of corneal NV has a high public health impact. Epigalloccatechin-3-gallate (EGCG), presenting antiangiogenesis effects, was chosen as an inhibitor to treat human vasc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nanomedicine
Main Authors: Chang, Che-Yi, Wang, Ming-Chen, Miyagawa, Takuya, Chen, Zhi-Yu, Lin, Feng-Huei, Chen, Ko-Hua, Liu, Guei-Sheung, Tseng, Ching-Li
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5221810/
https://ncbi.nlm.nih.gov/pubmed/28115846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S114754
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados